Skip to content

Apotheek Delrue: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek Delrue

BE 0715.967.985
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€25,549
2024 · €117,970-€92,421
Equity
€327,479
2024 · €382,787-€55,308
Cash
€224,293
2024 · €184,942+€39,351
Balance sheet total
€679,185
2024 · €715,387-€36,202

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets -€40,000

    down €40,000 (-25.0%), from €160,000 to €120,000

  • Cash +€39,351

    up €39,351 (+21.3%), from €184,942 to €224,293

    mainly Depreciation (+€46,473) and Other debts (+€36,259)

  • Receivables within one year -€19,546

    down €19,546 (-15.0%), from €130,458 to €110,912

    of which Trade receivables: -€40,713

  • Stocks and contracts -€9,585

    down €9,585 (-4.2%), from €229,812 to €220,227

Equity and liabilities
  • Reserves -€55,308

    down €55,308 (-14.9%), from €370,387 to €315,079

  • Other debts +€36,259

    up €36,259 (+19.8%), from €183,287 to €219,546

  • Current portion of long-term debt -€30,000

    down €30,000 (-75.0%), from €40,000 to €10,000

  • Trade debts +€28,771

    up €28,771 (+71.6%), from €40,182 to €68,954

  • Debts after one year -€10,000

    down €10,000 (-100%), from €10,000 to €0

Income statement
  • Gross operating margin -€144,133

    down €144,133 (-46.2%), from €312,179 to €168,046

  • Taxes -€43,449

    down €43,449 (-84.0%), from €51,723 to €8,274

  • Financial charges -€6,918

    down €6,918 (-34.8%), from €19,908 to €12,989

  • Depreciation -€3,766

    down €3,766 (-7.5%), from €50,238 to €46,473

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €117,970
Gross operating margin -€144,133
Staff costs -€1,845
Depreciation +€3,766
Other operating charges -€508
Financial income -€68
Financial charges +€6,918
Taxes +€43,449
Result 2025 €25,549
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€160,208
Investment €0
Financing -€120,857
Cash 2024 €184,942
Net result for the year +€25,549
Depreciation +€46,473
Stocks and contracts +€9,585
Receivables within one year +€19,546
Deferred charges and accrued income -€50
Trade debts +€28,771
Tax, wage and social debts +€813
Other debts +€36,259
Accrued charges and deferred income -€6,737
Debts after one year -€10,000
Current portion of long-term debt -€30,000
Contributions, distributions and other -€80,857
Cash 2025 €224,293
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €715,387 €679,185 -€36,202 -5.1%
Fixed assets 21/28 €168,243 €121,770 -€46,473 -27.6%
Intangible fixed assets 21 €160,000 €120,000 -€40,000 -25.0%
Tangible fixed assets 22/27 €8,242 €1,770 -€6,473 -78.5%
Plant, machinery and equipment 23 €501 €262 -€239 -47.7%
Furniture and vehicles 24 €7,742 €1,508 -€6,234 -80.5%
Current assets 29/58 €547,145 €557,416 +€10,271 +1.9%
Stocks and contracts in progress 3 €229,812 €220,227 -€9,585 -4.2%
Stocks 30/36 €229,812 €220,227 -€9,585 -4.2%
Amounts receivable within one year 40/41 €130,458 €110,912 -€19,546 -15.0%
Trade receivables 40 €129,897 €89,185 -€40,713 -31.3%
Other amounts receivable 41 €560 €21,727 +€21,167 +3,778%
Cash at bank and in hand 54/58 €184,942 €224,293 +€39,351 +21.3%
Deferred charges and accrued income 490/1 €1,933 €1,984 +€50 +2.6%
Total equity and liabilities 10/49 €715,387 €679,185 -€36,202 -5.1%
Equity 10/15 €382,787 €327,479 -€55,308 -14.4%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €370,387 €315,079 -€55,308 -14.9%
Distributable reserves 133 €370,387 €315,079 -€55,308 -14.9%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €332,601 €351,707 +€19,106 +5.7%
Amounts payable after more than one year 17 €10,000 €0 -€10,000 -100%
Financial debts 170/4 €10,000 €0 -€10,000 -100%
Amounts payable within one year 42/48 €305,069 €340,912 +€35,843 +11.7%
Current portion of amounts payable after more than one year 42 €40,000 €10,000 -€30,000 -75.0%
Trade debts 44 €40,182 €68,954 +€28,771 +71.6%
Suppliers 440/4 €40,182 €68,954 +€28,771 +71.6%
Taxes, remuneration and social security 45 €41,600 €42,412 +€813 +2.0%
Taxes 450/3 €25,496 €21,015 -€4,481 -17.6%
Remuneration and social security 454/9 €16,104 €21,397 +€5,293 +32.9%
Other amounts payable 47/48 €183,287 €219,546 +€36,259 +19.8%
Accrued charges and deferred income 492/3 €17,532 €10,795 -€6,737 -38.4%
Remuneration, social security and pensions 62 €73,327 €75,171 +€1,845 +2.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €50,238 €46,473 -€3,766 -7.5%
Other operating charges 640/8 €126 €634 +€508 +403%
Gross operating margin 9900 €312,179 €168,046 -€144,133 -46.2%
Operating profit (loss) 9901 €188,488 €45,768 -€142,720 -75.7%
Financial income 75/76B €1,112 €1,045 -€68 -6.1%
Recurring financial income 75 €1,112 €1,045 -€68 -6.1%
Financial charges 65/66B €19,908 €12,989 -€6,918 -34.8%
Recurring financial charges 65 €19,908 €12,989 -€6,918 -34.8%
Profit (loss) for the period before taxes 9903 €169,693 €33,823 -€135,869 -80.1%
Income taxes 67/77 €51,723 €8,274 -€43,449 -84.0%
Profit (loss) for the period 9904 €117,970 €25,549 -€92,421 -78.3%
Profit (loss) for the period to be appropriated 9905 €117,970 €25,549 -€92,421 -78.3%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.